IP Library Granted Patent US 12,290,806
Granted Patent B2
US 12,290,806 · App. 17/687,413 · Granted May 6, 2025

Substrate with channels for controlled fluid flow

Inventors: Samantha Chang (San Marcos, CA); Jason McClure (San Diego, CA); Robert Reed (Carlsbad, CA); Irene Sinn Blandy (San Diego, CA); Robert Weiller (Encinitas, CA); Christian Bobritchi (San Diego, CA)
Assignee: Ortho-Clinical Diagnostics, Inc.
B01L3/5023B01L3/5027G01N33/54389B01L2300/0858B01L2300/0861B01L2400/082G01N33/569
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,806
App. No.
17/687,413
Granted
May 6, 2025
Kind
B2
Abstract

A substrate structured to define thereon a fluid flow channel and/or a fluid control feature is described. The substrate may additionally comprise a capture zone and/or a test zone, for use as a test strip for determining presence or absence of an analyte of interest, such as an infectious agent or a biomarker. Reagents are deposited in the capture zone and/or test zone as an array of drops.

Claims (17)

1. A device, comprising:

a laminated structure comprising a nitrocellulose substrate layer provided on a hydrophobic support layer,

a plurality of parallel fluid flow channels, each parallel fluid flow channel separated from an adjacent parallel fluid flow channel by a nitrocellulose substrate-devoid gap exposing the hydrophobic support layer, wherein each substrate-devoid gap forms a side channel that is essentially impermeable to flow of an aqueous fluid;

a single sample receiving zone positioned on the substrate to distribute a portion of a sample deposited thereon into each fluid flow channel in the plurality of parallel fluid flow channels;

a fluid control feature ablated or etched on a surface of the nitrocellulose substrate, the fluid control feature composed of a nitrocellulose substrate-devoid area exposing the hydrophobic support layer, wherein the fluid control feature is configured to guide the portion of sample into one or more of the parallel fluid flow channels; and

a capture zone in each of the plurality of fluid flow channels, wherein the capture zone comprises a reagent comprising a binding member.

2. The device of claim 1 , wherein the plurality of fluid flow channels comprises between 3-50 fluid flow channels.

3. The device of claim 1 , wherein the hydrophobic support layer consists essentially of polyethylene terephthalate, one or more polyesters, and/or silicone.

4. The device of claim 1 , wherein the binding member comprises an immobilized binding member that binds a conjugate comprised of a detectable species and an antibody.

5. The device of claim 4 , wherein the detectable species is an antibody with a label.

6. The device of claim 5 , wherein the label is optically detectable.

7. The device of claim 6 , wherein the optically detectable label is a fluorescent or chemiluminescent marker.

8. The device of claim 6 , wherein the optically detectable label is a non-visually optically detectable label.

9. The device of claim 7 , wherein the detectable species is a europium bead.

10. The device of claim 1 , wherein the fluid control feature is in a flow rate control zone disposed downstream of the sample receiving zone.

11. The device of claim 10 , wherein the flow rate control zone is disposed between the sample receiving zone and the capture zone.

12. The device of claim 1 , wherein the device is an immunoassay device.

Assignments (5)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: QUIDEL CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0827 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2022
From: CHANG, SAMANTHA; MCCLURE, JASON; REED, ROBERT; BLANDY, IRENE SINN; WEILLER, ROBERT; BOBRITCHI, CHRISTIAN
To: QUIDEL CORPORATION
Reel/Frame 059490/0982 →